Title:
THERAPEUTIC TREATMENT
Document Type and Number:
WIPO Patent Application WO2005030215
Kind Code:
A3
Abstract:
A combination comprising candesartan and rosuvastatin for the prevention or treatment of arteriosclerosis and for the prevention of cardiovascular events is described.
Inventors:
MEHTA JAY LAL (US)
Application Number:
PCT/GB2004/004120
Publication Date:
June 02, 2005
Filing Date:
September 22, 2004
Export Citation:
Assignee:
ASTRAZENECA UK LTD (GB)
MEHTA JAY LAL (US)
MEHTA JAY LAL (US)
International Classes:
A61K31/4184; A61K31/505; (IPC1-7): A61K31/505; A61K31/4184
Domestic Patent References:
| WO2004096810A1 | 2004-11-11 | |||
| WO1995026188A1 | 1995-10-05 |
Foreign References:
| EP1314425A1 | 2003-05-28 |
Other References:
CHEN JIAWEI ET AL: "Marked upregulation of lipoxygenase-1, a receptor for ox-low-density lipoprotein in atherosclerosis, and its total ablation by candesartan and rosuvastatin given concurrently.", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 43, no. 5 Supplement A, 3 March 2004 (2004-03-03), & 53RD ANNUAL SCIENTIFIC SESSION OF THE AMERICAN COLLEGE OF CARDIOLOGY; NEW ORLEANS, LA, USA; MARCH 07-10, 2004, pages 498A, XP002319611, ISSN: 0735-1097
PATENT ABSTRACTS OF JAPAN vol. 2002, no. 09 4 September 2002 (2002-09-04)
PATENT ABSTRACTS OF JAPAN vol. 2002, no. 09 4 September 2002 (2002-09-04)
Download PDF: